Ms. Lela Lankerani, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 S Us Highway 281, Marble Falls, TX 78654 Phone: 830-693-4800 Fax: 830-626-9031 |
News Archive
By furthering scientists' understanding of the molecular mechanisms that separate the minority of successful HIV antibodies from the majority of ineffective antibodies, the work may have implications for future attempts to design an HIV vaccine.
A study conducted by LSU Health New Orleans researchers provides new evidence that early exposure to multiple health disciplines in pipeline programs targeting underserved/underrepresented students interested in health professions reduces the development of traditional role and leadership stereotypes about professional health care teams and practice.
Acetylon Pharmaceuticals today announced the initiation of patient treatments in a three-part Phase 1-2a clinical trial of ACY-1215, an oral Class II histone deacetylase (HDAC) inhibitor, in adults with relapsed and relapsed/refractory multiple myeloma.
Glioblastomas are the most common malignant brain tumors in adults. Treatment options are extremely limited and usually not effective, leading to death for most patients within 12-18 months of diagnosis.
"They are strong drug candidates for the treatment of human coronavirus infections because they have already been successful in animals (cats)," writes the team. "The work here lays the framework for their use in human trials for the treatment of COVID-19."
› Verified 7 days ago